Prospective registry study of primary dyslipidemia

Prospective registry study of primary dyslipidemia - PROLIPID

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042782

Enrollment

1000

Registered

2020-12-20

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Homozygous familial hypercholesterolemia (homo-FH) Heterozygous familial hypercholesterolemia (hetero-FH) Type III Hyperlipoproteinemia Familial chylomicronemia Sitosterolemia Cerebrotendinous xanthomatosis Lecithin cholesterol acyltransferase (LCAT) deficiency Tangier disease Abetalipoproteinemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical and/or genetic diagnosis of the following Primary dyslipidemia: Homozygous familial hypercholesterolemia (homo-FH) Heterozygous familial hypercholesterolemia (hetero-FH) Type III Hyperlipoproteinemia Familial chylomicronemia Sitosterolemia Cerebrotendinous xanthomatosis Lecithin cholesterol acyltransferase (LCAT) deficiency Tangier disease Abetalipoproteinemia

Exclusion criteria

Exclusion criteria: Patients who refused to consent

Design outcomes

Primary

Measure	Time frame
Incidence of adverse outcomes in patients with primary dyslipidemia [Through study completion]	—

Secondary

Measure	Time frame
All-cause mortality [Through study completion]	—

Countries

Japan

Contacts

Public ContactMasatsune Ogura

National Cerebral and Cardiovascular Center Department of Molecular Innovation in Lipidology

enustasam@ncvc.go.jp06-6170-1070

Outcome results